Sponsor Check › Person
Related person on Form D filings · address states as listed: PA, MD, RI, NJ, NC · listed Feb 3, 2010 → Mar 24, 2026
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:55 PM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:55 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:55 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
0 of 39 offerings report sales commissions; 0 report finder's fees; 2 report proceeds to related persons totalling $1,211,250. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Aug 7, 2026 D/A File 021-413103 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 24, 2026 D File 021-577527 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 24, 2026 D File 021-577529 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 24, 2026 D File 021-577531 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 29, 2025 D File 021-568138 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 23, 2025 D File 021-552604 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 12, 2024 D File 021-529208 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 23, 2023 D/A File 021-441252 | $0 | $0 | $0 A management fee, initially equal to a percentage of committed capital, is payable to the Investment Manager and will be used, in part, to provide compensation to Related Persons. | Anne Enna BrokerCheck CRD 2537451 ↗ via Hollister Associates, LLC (CRD 173366 ↗) Lawrence Hollin BrokerCheck CRD 1324425 ↗ via Invicta Capital, LLC (CRD 288101 ↗) |
| EDGAR ↗ | Jun 16, 2023 D/A File 021-441235 | $0 | $0 | $0 A management fee, initially equal to a percentage of committed capital, is payable to the Investment Manager and will be used, in part, to provide compensation to Related Persons. | Anne Enna BrokerCheck CRD 2537451 ↗ via Hollister Associates, LLC (CRD 173366 ↗) |
| EDGAR ↗ | Dec 10, 2020 D File 021-382871 | $0 | $0 | $300,000 (est.) A portion of the proceeds may be used for normal payroll and benefits costs of officers who are also employees of the Issuer. | None listed on this filing |
| EDGAR ↗ | Aug 7, 2020 D/A File 021-366022 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 16, 2019 D File 021-346722 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 16, 2019 D/A File 021-285374 | $0 | $0 | $0 Proceeds to be used for general working capital purposes. | None listed on this filing |
| EDGAR ↗ | Jul 10, 2019 D File 021-343859 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 7, 2019 D/A File 021-302235 | $0 | $0 | $0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. | None listed on this filing |
| EDGAR ↗ | Apr 15, 2019 D File 021-337332 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 4, 2018 D File 021-327119 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 14, 2018 D File 021-312279 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 4, 2018 D File 021-311681 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 20, 2018 D File 021-310721 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 2, 2018 D File 021-309088 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 14, 2018 D File 021-305660 | $0 | $0 | $0 A management fee, initially equal to a percentage of committed capital, is payable to the Investment Manager and will be used, in part, to provide compensation to Related Persons. | Anne Enna no CRD number reported via Hollister Associates, LLC (CRD 173366 ↗) |
| EDGAR ↗ | Jan 4, 2018 D File 021-302368 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 2, 2017 D File 021-297970 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 16, 2017 D/A File 021-218559 | $0 | $0 | $0 Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering. | None listed on this filing |
| EDGAR ↗ | Jan 27, 2017 D File 021-279421 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 23, 2016 D/A File 021-236876 | $0 | $0 | $0 A management fee, initially equal to a percentage of committed capital, is payable to the Investment Manager and will be used, in part, to provide compensation to Related Persons. | None listed on this filing |
| EDGAR ↗ | Nov 24, 2014 D File 021-228944 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 8, 2014 D File 021-226029 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 13, 2012 D/A File 021-177698 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 20, 2012 D File 021-172232 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 29, 2011 D File 021-169324 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 6, 2011 D File 021-162359 | $0 | $0 | $0 Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering. | None listed on this filing |
| EDGAR ↗ | Feb 11, 2011 D/A File 021-154151 | $0 | $0 | $0 Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering. | None listed on this filing |
| EDGAR ↗ | Dec 21, 2010 D File 021-152302 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 4, 2010 D File 021-148506 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 3, 2010 D File 021-123071 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 21, 2009 D File 021-116058 | $0 | $0 | $911,250 (est.) Represents estimated total compensation for 1 year for the Executive Officers listed under #3, Related Persons | None listed on this filing |
| EDGAR ↗ | May 27, 2009 D/A File 021-118709 | $0 | $0 | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Onkos Surgical, Inc. | Director | Aug 7, 2026 | D/A | $37,245,260 similar: $829,831–$9,999,998 | $37,245,260 | 16 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | 1315 Capital Fund IV Family Access Fund, L.P. group: 1315 Capital Emerging | Executive Officer PARTNER OF THE INVESTMENT MANAGER | Mar 24, 2026 | D | Indefinite similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | 1315 Capital IV, L.P. group: 1315 Capital Emerging | Executive Officer PARTNER OF THE INVESTMENT MANAGER | Mar 24, 2026 | D | Indefinite similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | 1315 Capital Emerging Growth & Buyout II, L.P. group: 1315 Capital Emerging | Executive Officer PARTNER OF THE INVESTMENT MANAGER | Mar 24, 2026 | D | Indefinite similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | 1315 Capital CPI Co-Invest, L.P. group: 1315 Capital Emerging | Executive Officer, Director Sole Member of (i) the General Partner of the General Partner and (ii) the General Partner of the Managing Member of the Investment Manager | Dec 29, 2025 | D | $20,500,000 similar: $155,000–$5,250,000 | $20,500,000 | 6 similar: 4–27 | $860,000 similar: $1,000–$100,000 |
| EDGAR ↗ | 1315 Capital Co-Invest Nu-Tek, L.P. group: 1315 Capital Emerging | Executive Officer, Director Sole Member of (i) the General Partner of the General Partner and (ii) the General Partner of the Managing Member of the Investment Manager | Jul 23, 2025 | D | $4,500,000 similar: $155,000–$5,250,000 | $4,500,000 | 1 similar: 4–27 | $4,500,000 similar: $1,000–$100,000 |
| EDGAR ↗ | 1315 Capital Co-Invest Subzero, L.P. group: 1315 Capital Emerging | Executive Officer, Director Managing Member of (i) the General Partner and (ii) the Managing Member of the Investment Manager | Nov 12, 2024 | D | $25,500,000 similar: $155,000–$5,250,000 | $25,500,000 | 5 similar: 4–27 | $1,586,896 similar: $1,000–$100,000 |
| EDGAR ↗ | 1315 Capital Emerging Growth & Buyout, L.P. group: 1315 Capital Emerging | Executive Officer, Director Managing Member of (i) the General Partner and (ii) the Investment Manager | Oct 23, 2023 | D/A | $162,000,000 similar: $155,000–$5,250,000 | $162,000,000 | 51 similar: 4–27 | $100,000 similar: $1,000–$100,000 |
| EDGAR ↗ | 1315 Capital III, L.P. group: 1315 Capital Emerging | Executive Officer, Director Managing Member of (i) the General Partner and (ii) the Managing Member of the Investment Manager | Jun 16, 2023 | D/A | $350,000,000 similar: $155,000–$5,250,000 | $350,000,000 | 57 similar: 4–27 | $100,000 similar: $1,000–$100,000 |
| EDGAR ↗ | Onkos Surgical, Inc. | Director | May 12, 2023 | D/A | $33,500,001 similar: $829,831–$9,999,998 | $33,500,001 | 17 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | 1315 Capital Emerging Growth & Buyout, L.P. group: 1315 Capital Emerging | Executive Officer, Director Managing Member of (i) the General Partner and (ii) the Managing Member of the Investment Manager | Dec 16, 2022 | D/A | $150,000,000 similar: $155,000–$5,250,000 | $98,750,000 | 39 similar: 4–27 | $100,000 similar: $1,000–$100,000 |
| EDGAR ↗ | Onkos Surgical, Inc. | Director | Jun 16, 2022 | D/A | $26,500,001 similar: $829,831–$9,999,998 | $26,500,001 | 16 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | 1315 Capital Emerging Growth & Buyout, L.P. group: 1315 Capital Emerging | Executive Officer, Director Managing Member of (i) the General Partner and (ii) the Managing Member of the Investment Manager | May 27, 2022 | D/A | $150,000,000 similar: $155,000–$5,250,000 | $85,650,000 | 34 similar: 4–27 | $100,000 similar: $1,000–$100,000 |
| EDGAR ↗ | 1315 Capital III, L.P. group: 1315 Capital Emerging | Executive Officer, Director Managing Member of (i) the General Partner and (ii) the Managing Member of the Investment Manager | May 27, 2022 | D/A | $350,000,000 similar: $155,000–$5,250,000 | $238,750,000 | 45 similar: 4–27 | $100,000 similar: $1,000–$100,000 |
| EDGAR ↗ | 1315 Capital Emerging Growth & Buyout, L.P. group: 1315 Capital Emerging | Executive Officer, Director Managing Member of (i) the General Partner and (ii) the Managing Member of the Investment Manager | Apr 11, 2022 | D | $150,000,000 similar: $155,000–$5,250,000 | $79,200,000 | 32 similar: 4–27 | $100,000 similar: $1,000–$100,000 |
| EDGAR ↗ | 1315 Capital III, L.P. group: 1315 Capital Emerging | Executive Officer, Director Managing Member of (i) the General Partner and (ii) the Managing Member of the Investment Manager | Apr 11, 2022 | D | $350,000,000 similar: $155,000–$5,250,000 | $227,700,000 | 44 similar: 4–27 | $100,000 similar: $1,000–$100,000 |
| EDGAR ↗ | Onkos Surgical, Inc. | Director | Nov 18, 2021 | D/A | $22,499,999 similar: $829,831–$9,999,998 | $22,499,999 | 15 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Onkos Surgical, Inc. | Director | Sep 13, 2021 | D | $15,000,000 similar: $829,831–$9,999,998 | $15,000,000 | 14 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Sprout2 Inc. | Director | Dec 10, 2020 | D | $10,000,000 similar: $1,694,259–$16,000,000 | $8,126,129 | 59 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Onkos Surgical, Inc. | Director | Aug 7, 2020 | D/A | $12,000,000 similar: $829,831–$9,999,998 | $10,106,312 | 14 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Onkos Surgical, Inc. | Director | Apr 30, 2020 | D | $12,000,000 similar: $829,831–$9,999,998 | $7,571,313 | 11 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Sprout2 Inc. | Director | Aug 16, 2019 | D | $20,000,000 similar: $1,694,259–$16,000,000 | $15,900,000 | 110 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Onkos Surgical, Inc. | Director | Jul 16, 2019 | D/A | $22,599,998 similar: $829,831–$9,999,998 | $22,599,998 | 7 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | TELA Bio, Inc. | Director | Jul 10, 2019 | D | $20,000,000 similar: $2,000,000–$19,999,994 | $10,623,181 | 15 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | NovaSom, Inc group: Sleep | Director | Jun 7, 2019 | D/A | $7,550,000 similar: $829,831–$9,999,998 | $7,550,000 | 6 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Encore Dermatology, Inc. | Director | Apr 15, 2019 | D | $41,200,702 similar: $829,831–$9,999,998 | $32,948,012 | 11 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | NovaSom, Inc group: Sleep | Director | Mar 20, 2019 | D/A | $6,850,000 similar: $829,831–$9,999,998 | $6,850,000 | 6 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | NovaSom, Inc group: Sleep | Director | Feb 8, 2019 | D/A | $6,100,000 similar: $829,831–$9,999,998 | $6,100,000 | 6 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | NovaSom, Inc group: Sleep | Director | Jan 3, 2019 | D/A | $5,500,000 similar: $829,831–$9,999,998 | $5,500,000 | 6 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | TELA Bio, Inc. | Director | Dec 4, 2018 | D | $3,500,000 similar: $2,000,000–$19,999,994 | $2,067,080 | 8 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | TELA Bio, Inc. | Director | May 14, 2018 | D | $2,000,000 similar: $2,000,000–$19,999,994 | $501,120 | 1 similar: 2–16 | $250,000 similar: $10,000–$50,000 |
| EDGAR ↗ | TELA Bio, Inc. | Director | May 4, 2018 | D | $240,000 similar: $2,000,000–$19,999,994 | $240,000 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | TELA Bio, Inc. | Director | Apr 20, 2018 | D | $500,000 similar: $2,000,000–$19,999,994 | $500,000 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | TELA Bio, Inc. | Director | Apr 2, 2018 | D | $1,000,000 similar: $2,000,000–$19,999,994 | $500,000 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | NovaSom, Inc group: Sleep | Director | Mar 29, 2018 | D/A | $3,700,000 similar: $829,831–$9,999,998 | $3,700,000 | 6 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | 1315 Capital II, L.P. group: 1315 Capital Emerging | Executive Officer, Director Manager and Member of the General Partner and the Investment Manager | Feb 14, 2018 | D | $300,000,000 similar: $155,000–$5,250,000 | $300,000,000 | 57 similar: 4–27 | $100,000 similar: $1,000–$100,000 |
| EDGAR ↗ | Sprout2 Inc. | Director | Jan 4, 2018 | D | $6,600,000 similar: $1,694,259–$16,000,000 | $4,500,000 | 203 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | NovaSom, Inc group: Sleep | Director | Jan 3, 2018 | D | $3,300,000 similar: $829,831–$9,999,998 | $1,000,000 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | TELA Bio, Inc. | Director | Nov 2, 2017 | D | $25,000,000 similar: $2,000,000–$19,999,994 | $15,000,000 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Onkos Surgical, Inc. | Director | Apr 24, 2017 | D | $17,599,996 similar: $829,831–$9,999,998 | $12,599,997 | 7 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | NovaSom, Inc group: Sleep | Director | Mar 16, 2017 | D/A | $8,004,500 similar: $829,831–$9,999,998 | $6,004,500 | 6 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | TELA Bio, Inc. | Director | Jan 27, 2017 | D | $7,500,000 similar: $2,000,000–$19,999,994 | $7,386,295 | 16 similar: 2–16 | $50,000 similar: $10,000–$50,000 |
| EDGAR ↗ | NovaSom, Inc group: Sleep | Director | Apr 22, 2016 | D/A | $5,004,500 similar: $829,831–$9,999,998 | $5,004,500 | 6 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | 1315 Capital, L.P. | Executive Officer Manager and Member of the General Partner and the Investment Manager | Mar 23, 2016 | D/A | $225,000,000 similar: $155,000–$5,250,000 | $179,469,000 | 45 similar: 4–27 | $100,000 similar: $1,000–$100,000 |
| EDGAR ↗ | 1315 Capital, L.P. | Executive Officer Manager and Member of the General Partner and the Investment Manager | Mar 30, 2015 | D | $225,000,000 similar: $155,000–$5,250,000 | $60,000,000 | 22 similar: 4–27 | $100,000 similar: $1,000–$100,000 |
| EDGAR ↗ | TELA Bio, Inc. | Director | Nov 24, 2014 | D | $500,000 similar: $2,000,000–$19,999,994 | $500,000 | 1 similar: 2–16 | $500,000 similar: $10,000–$50,000 |
| EDGAR ↗ | TELA Bio, Inc. | Director | Oct 8, 2014 | D | $45,370,140 similar: $2,000,000–$19,999,994 | $45,370,140 | 29 similar: 2–16 | $20,000 similar: $10,000–$50,000 |
| EDGAR ↗ | NovaSom, Inc group: Sleep | Director | Jul 22, 2014 | D/A | $4,000,000 similar: $829,831–$9,999,998 | $3,004,500 | 5 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | NovaSom, Inc group: Sleep | Director | Jun 4, 2014 | D | $4,000,000 similar: $829,831–$9,999,998 | $3,000,000 | 3 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Precision Dermatology, Inc. | Director | Nov 13, 2012 | D/A | $58,100,001 | $55,000,001 | 0 | No minimum reported |
| EDGAR ↗ | Nitric BioTherapeutics, Inc. | Director | Jan 20, 2012 | D | $1,250,000 | $1,020,000 | 4 | No minimum reported |
| EDGAR ↗ | Nitric BioTherapeutics, Inc. | Director | Nov 29, 2011 | D | $1,000,000 | $1,000,000 | 1 | No minimum reported |
| EDGAR ↗ | NovaSom, Inc group: Sleep | Director | Jul 6, 2011 | D | $34,694,393 | $34,694,393 | 18 | No minimum reported |
| EDGAR ↗ | NovaSom, Inc group: Sleep | Director | Feb 11, 2011 | D/A | $15,000,000 | $9,494,395 | 17 | No minimum reported |
| EDGAR ↗ | NovaSom, Inc group: Sleep | Director | Jan 21, 2011 | D | $15,000,000 | $8,077,411 | 2 | No minimum reported |
| EDGAR ↗ | SEMPRAE LABORATORIES INC | Director | Dec 21, 2010 | D | $10,100,000 | $4,100,000 | 3 | No minimum reported |
| EDGAR ↗ | SEMPRAE LABORATORIES INC | Director | Oct 4, 2010 | D | $5,000,000 | $1,000,000 | 1 | No minimum reported |
| EDGAR ↗ | SEMPRAE LABORATORIES INC | Director | Feb 3, 2010 | D | $3,106,000 | $3,106,000 | 9 | No minimum reported |
| EDGAR ↗ | SLEEP SOLUTIONS INC group: Sleep | Director | Sep 21, 2009 | D | $20,000,000 | $20,000,000 | 8 | No minimum reported |
| EDGAR ↗ | OCEANA THERAPEUTICS, INC. | Director | May 27, 2009 | D/A | $50,000,001 | $3,000,000 | 4 | $16,770 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); Pooled Investment Fund / 506(b) (83,801 filings); Pharmaceuticals / 506(b) (800 filings); Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Separate person records under the same name, not combined with this page. Each line says whether it is listed on an issuer this record is also listed on (a second identifier); where it is not, it could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as Adele C. Oliva. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Adele C. Oliva appears on a new Form D, or when a court case or SEC action is matched to them. See plans →